$NCSM

LEV ORI sold (to issuer) 10,758 shares of NCSM

LEV ORI (See Remarks) sold (to issuer) 10,758 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · LEV ORI
Published Sep 1, 2026, 1:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

The sale is small relative to the company's float and does not indicate a significant shift in insider sentiment.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming corporate actions not disclosed in filing

Relevance 4/10Novelty 4/10Timing: after-hours filing

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$NCSMNeutralMedium confidence
Context

Officer reported sale of 10,758 shares to issuer in a Form 4 filing

Expected impact

Potential slight downward pressure

Evidence & confidence

Small insider sell without disclosed price; no material change in ownership

Market effects

Minimal effect on the broader sector; typical insider activity

Negligible impact on regional markets

None

Counterpoint

Sale may reflect insider confidence in future buyback opportunities

Key entities

  • LEV ORI

    Reporting insider who sold shares

  • NCS Multistage Holdings, Inc.

    Issuer of the shares sold

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).